A new study in Small presents a nanoparticle-based delivery system combining CuET and BIO for treating resistant melanoma, ...

Results: The frequency of CD103 + CD69 + CD8 + Trm cells and CD14 + CD16 + monocytes was significantly higher in BA than in the control group. In BA, T cells showed elevated expression of CD103, CD69, ...

When reviewing T-cell activation levels, the combination dampened IL-6 and CD4+ CD69+ and the investigators noted that high doses of runimotamab (≥30/90 mg) can further boost cytokine secretion and ...

Liver NK cell CD69: washed LMCs were labelled with Fluorescein isothiocyanate ... p Values were calculated by the two-sided paired t-test for single points or groups, and statistical significance is ...

Memorial Sloan Kettering Cancer Center investigators report that T cell interferon-γ (IFNγ) orchestrates a ...

As people age, their immune systems become less efficient, posing a challenge for cancer therapies that rely on harnessing ...

During a live event, Nathan M. Denlinger, DO, MS, discussed the PILOT and ALYCANTE trials of CAR T-cell therapy in transplant-ineligible B-cell lymphoma.

After treatment with CAR-T cells—immune cells engineered to attack cancer—patients sometimes tell their doctors they feel like they have “brain fog,” or forgetfulness and difficulty ...